Share Name Share Symbol Market Type Share ISIN Share Description
Itaconix Plc LSE:ITX London Ordinary Share GB00B84LVH87 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 3.33% 1.55 1.50 1.60 1.55 1.50 1.50 719,226 08:43:28
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 0.7 -7.4 -4.6 - 4

Itaconix PLC Sale of Minority Interest in Alkalon

29/05/2019 7:00am

UK Regulatory (RNS & others)

Itaconix (LSE:ITX)
Historical Stock Chart

6 Months : From Apr 2019 to Oct 2019

Click Here for more Itaconix Charts.


RNS Number : 3916A

Itaconix PLC

29 May 2019

29 May 2019

Itaconix plc ("Itaconix" or "the Company")

Sale of Minority Interest in Alkalon

Itaconix (AIM: ITX), a leading innovator in sustainable specialty polymers, announces the sale of its holdings in Alkalon A/S ("Alkalon"), a privately-held Danish nicotine gum company. The Company's holdings in Alkalon were purchased for cash by Helmich Invest ApS, Nolta ApS, Solco ApS, and Commerce Pharma Holding ApS, who are existing shareholders in Alkalon. The total cash consideration was c. DKK 2.0 million, equivalent to c. GBP242,000. The proceeds consisted of c. GBP194,000 for the Company's minority equity interest in Alkalon and c. GBP48,000 for the full principal and accrued interest of a shareholder loan.

Following impairments for fair value in 2016 and 2017, the book values for Alkalon in Itaconix's unaudited management accounts at 31 December 2018 were GBP46,000 for the minority equity interest in Alkalon and GBP30,000 for the shareholder loan and its accrued interest.

Itaconix held 22.49% of Alkalon's ordinary shares. The Company recognised a profit of c.GBP5,000 for its share of Alkalon's profits in its unaudited management accounts for the year ended 31 December 2018 and a loss of c.GBP214,000 for the year ended 31 December 2017.

As announced in 2016, Itaconix divested its nicotine gum business in return for an initial 15% equity holding in Alkalon. Subsequent shares from commercial milestones and minority participation in equity and debt funding increased the Company's stake to its holdings at the time of the sale.

Proceeds from the sale will be added to the Company's cash reserves and used for future working capital needs.

John R. Shaw, CEO of Itaconix, stated: "The sale of these last assets from Revolymer's legacy nicotine gum business marks the final step in transforming Itaconix into a technology innovator focused on emerging demands for sustainable specialty polymers."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).


For further information please contact:

Itaconix plc                              +1 603 775-4400 
John R. Shaw / Michael Norris 
N+1 Singer                                +44 (0) 207 496 3000 
Richard Lindley / James Moat (Corporate 
 Mia Gardner (Corporate Broking) 

About Itaconix

Itaconix develops and produces bio-based specialty polymers that improve the safety, performance or sustainability of consumer and industrial products, with technology and market leadership positions in non-phosphate detergents, odour control, and hair styling.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

May 29, 2019 02:00 ET (06:00 GMT)

1 Year Itaconix Chart

1 Year Itaconix Chart

1 Month Itaconix Chart

1 Month Itaconix Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191022 21:52:47